Risperdal Lawsuit News: $2.2 Billion Federal Settlement Was Pennsylvania’s Largest Qui Tam Case, Ber
The Firm is representing numerous Risperdal lawsuit clients who allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic medication. New York, New York (PRWEB) November 12, 2014 As the litigation involving Risperdal and gynecomastia (http://www.risperdallawsuit2014.com/risperdal-gynecomastia/) continues to grow, Bernstein Liebhard LLP notes that last year’s landmark $2.2 billion settlement between the manufacturers of the drug and the federal government was Pennsylvania’s largest involving a qui tam, or whistleblower case. A recent analysis of co
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Related Documents in PR Web
- Changing the Patent Debate: Study Finds Potential Benefits To U.S. Economic Growth of Up to $200 Bil
- InfoStretch is Ranked in the Biz Journal List of 50 Fastest-Growing Private Companies in Silicon Val
- North American Title Insurance Co. and Safe Escrow Partner to Offer Title Agents a Managed Disbursem
Categories
- Articles 313
- Bankruptcy 44
- Business 134
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4